Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)

Xuanzhu Biopharmaceutical Revenue

In the year 2025, Xuanzhu Biopharmaceutical had annual revenue of 51.77M CNY with 72.03% growth. Xuanzhu Biopharmaceutical had revenue of 33.88M in the half year ending December 31, 2025.

• Revenue: 51.77M CNY
• Revenue Growth: +72.03%
• P/S Ratio: 152.65
• Revenue / Employee: 151.38K CNY
• Employees: 342
• Market Cap: 8.79B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	51.77M	21.68M	72.03%
Dec 31, 2024	30.09M	30.07M	103,672.41%
Dec 31, 2023	29.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 31, 2026

Data Sources Report a data error